Capricor Therapeutics
CAPR
#5617
Rank
$1.39 B
Marketcap
$24.08
Share price
1.18%
Change (1 day)
142.50%
Change (1 year)

Capricor Therapeutics (CAPR) Fails to deliver data

Key failure to deliver metrics for Capricor Therapeutics :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Capricor Therapeutics (CAPR) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Capricor Therapeutics (CAPR) - since 2019

Volume in USD (price x number of shares), data since 2019

Capricor Therapeutics (CAPR) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026$7.18 M-95.44%
2025$0.15 B154.62%
2024$61.89 M1584.06%
2023$3.67 M24.67%
2022$2.94 M-49.93%
2021$5.88 M-88.57%
2020$51.49 M573.14%
2019$7.65 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Johnson & Johnson
JNJ
$0.14 B$0.27 B๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
$58.89 M$68.05 M๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
$0.23 B$0.27 B๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
$0.86 M$11.01 M๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
$0.27 M$1.38 M๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
$0.01 M$4.79 M๐Ÿ‡บ๐Ÿ‡ธ USA